1. 1. Park J, Park JW, Kang MK (2019) Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma. Yeungnam University Journal of Medicine, 36(3): 192-200. [ DOI:10.12701/yujm.2019.00269] [ PMID] [ ] 2. Rosenzweıg K (2017) Stereotactic body radiation therapy as an alternative to surgery in early-stage non-small-cell lung cancer. Oncology, 31(6): 492-8. 3. Milano MT (2019) Stereotactic body radiotherapy as salvage treatment for recurrence of non-small cell lung cancer after prior surgery or radiotherapy. Translational Lung Cancer Research, 8(1): 78. [ DOI:10.21037/tlcr.2018.08.15] [ PMID] [ ] 4. Zheng X, Schipper M, Kidwell K, et al. (2014) Survival outcome after SBRT and surgery for stage I non-small cell lung cancer: a meta-analysis. Int J RadiatOncol Biol Phys, 90(3): 603-611. [ DOI:10.1016/j.ijrobp.2014.05.055] [ PMID] 5. Simone II CB, Wildt B, Haas AR, et al. (2013) Stereotactic body radiation therapy for lung cancer. Chest, 143(6): 1784-1790. [ DOI:10.1378/chest.12-2580] [ PMID] 6. He C, Liu YM, Cerra-Franco A, et al. Long-term survival after salvage SBRT for recurrent or secondary non-small cell lung cancer after prior surgery or radiation therapy. J Clin Oncol 2018; 36: abstr 8558. [ DOI:10.1200/JCO.2018.36.15_suppl.8558] 7. Milano MT, Mihai A, Kong FM (2018) Review of thoracic reirradiation with stereotactic body radiation therapy: A focus on toxicity risks. Pract Radiat Oncol, 8:251-65. [ DOI:10.1016/j.prro.2018.01.008] [ PMID] 8. Videtic GM, Donington J, Giuliani M, et al. (2017) SBRT for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline. Practical Radiation Oncology, 7(5): 295-301. [ DOI:10.1016/j.prro.2017.04.014] [ PMID] 9. James K, Eisenhauer E, Christian M, et al. (1999) Measuring response in solid tumors: unidimensional versus bidimensional measurement. Journal of the National Cancer Institute, 91(6): 523-528. [ DOI:10.1093/jnci/91.6.523] [ PMID] 10. Trotti A, Colevas AD, Setser A, et al. (2003) CTCAE v3.0: development of a comprehensive grading for the adverse effects of cancer treatment. Seminars in Radiation Oncology, 13(3): 176-181. [ DOI:10.1016/S1053-4296(03)00031-6] [ PMID] 11. Dingemans AMC, Hendriks LE, Berghmans T, et al. (2019) Definition of synchronous oligometastatic non-small cell lung cancer-a consensus report. Journal of Thoracic Oncology, 14(12): 2109-2119. [ DOI:10.1016/j.jtho.2019.07.025] [ PMID] 12. Lo SS, Fakiris AJ, Chang EL, et al. (2010) Stereotactic body radiation therapy: a novel treatment modality. Nature Reviews Clinical Oncology, 7(1): 44-54. [ DOI:10.1038/nrclinonc.2009.188] [ PMID] 13. Kelly P, Balter PA, Rebueno N, et al. (2010) SBRT for patients with lung cancer previously treated with thoracic radiation. Int J Radiat Oncol Biol Phys, 78(5): 1387-1393. [ DOI:10.1016/j.ijrobp.2009.09.070] [ PMID] [ ] 14. Ceylan C, Hamaci A, Ayata H, et al. (2017) Re-irradiation of locoregional NSCLC recurrence using robotic SBRT. Oncology Research and Treatment, 40(4): 207-214. [ DOI:10.1159/000457129] [ PMID] 15. Timmerman RD, Paulus R, Pass, HI, et al. (2018) Stereotactic body radiation therapy for operable early-stage lung cancer: findings from the NRG oncology RTOG 0618 trial. JAMA Oncology, 4(9): 1263-1266. [ DOI:10.1001/jamaoncol.2018.1251] [ PMID] [ ] 16. Senthi S, Lagerwaard FJ, Haasbeek CJ, et al. (2012) Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-smallcell lung cancer: a retrospective analysis. Lancet Oncol, 13: 802-809. [ DOI:10.1016/S1470-2045(12)70242-5] [ PMID] 17. Matsuo Y, Shibuya K, Nagata Y, et al. (2012) Preliminary report of late recurrences, at 5 years or more, after SBRT for non-small cell lung cancer. J Thoracic Oncology, 7(2): 453-456. [ DOI:10.1097/JTO.0b013e31823c5b29] [ PMID] 18. Parks J, Kloecker G, Woo S, Dunlap NE (2016) SBRT as salvage for intrathoracic recurrence in patients with previously irradiated locally advanced non-small cell lung cancer. American Journal of Clinical Oncology, 39(2): 147-153. [ DOI:10.1097/COC.0000000000000039] [ PMID] 19. Kilburn JM, Kuremsky JG, Blackstock, et al. (2014) Thoracic re-irradiation using SBRT techniques as first or second course of treatment. Radiotherapy and Oncology, 110(3): 505-510. [ DOI:10.1016/j.radonc.2013.11.017] [ PMID] [ ] 20. Patel NR, Lanciano R, Sura K, et al. (2015) SBRT for re-irradiation of lung cancer recurrence with lower biological effective doses. J Radiat Oncol, 4(1): 65-70. [ DOI:10.1007/s13566-014-0175-2] [ PMID] [ ] 21. Horne ZD, Dohopolski MJ, Clump DA, et al. (2018) Thoracic reirradi. with SBRT for residual/recurrent and new pri. NSCLC within or adjacent to a prior high-dose radiation field. Practical Radiat Oncol, 8(3): e117-e123. [ DOI:10.1016/j.prro.2017.11.011] [ PMID] 22. Agolli L, Valeriani M, Carnevale A, et al. (2015) Role of salvage SBRT in post-surgical loco-regional recurrence in a selected population of NSCLC patients. Anticancer Research, 35(3): 1783-1789. 23. Keidar Z, Haim N, Guralnik L, et al. (2004) PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management. Journal of Nuclear Medicine, 45(10): 1640-1646.
|